Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume $4.39 -0.39 (-8.16%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$4.60 +0.21 (+4.67%) As of 06/13/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aptevo Therapeutics Short Interest DataAptevo Therapeutics (APVO) has a short interest of 9,400 shares, representing 1.39% of the float (the number of shares available for trading by the public). This marks a -55.02% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 76,808 shares to cover all short positions.Current Short Interest9,400 sharesPrevious Short Interest20,900 sharesChange Vs. Previous Month-55.02%Dollar Volume Sold Short$44.65 thousandShort Interest Ratio0.0 Days to CoverLast Record DateMay 31, 2025Outstanding Shares405,000 sharesFloat Size677,600 sharesShort Percent of Float1.39%Today's Trading Volume146,724 sharesAverage Trading Volume76,808 sharesToday's Volume Vs. Average191% Short Selling Aptevo Therapeutics? Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPVO Short Interest Over TimeAPVO Days to Cover Over TimeAPVO Percentage of Float Shorted Over Time Aptevo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20259,400 shares $44.65 thousand -55.0%1.4%0 $4.75 5/15/202520,900 shares $6.90 thousand -95.4%1.4%0.1 $0.33 4/30/2025452,300 shares $239.72 thousand -35.7%N/A0.2 $0.53 4/15/2025703,600 shares $675.46 thousand +82.0%23.3%0.3 $0.96 3/31/2025386,500 shares $448.34 thousand +220.5%12.0%0.2 $1.16 3/15/2025120,600 shares $290.65 thousand +100.7%8.3%1.8 $2.41 2/28/202560,100 shares $229.58 thousand +155.7%4.1%0.3 $3.82 2/15/202523,500 shares $78.49 thousand -46.2%1.6%0.1 $3.34 1/31/202543,700 shares $191.41 thousand +64.9%3.0%0.2 $4.38 1/15/202526,500 shares $120.58 thousand +39.5%1.8%0.1 $4.55 Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202419,000 shares $81.89 thousand -92.1%1.3%0.1 $4.31 12/15/2024241,700 shares $988.55 thousand +536.1%16.6%0.8 $4.09 11/30/202438,000 shares $14.57 million -94.8%7.6%0.2 $383.32 11/15/2024734,600 shares $155.00 thousand -38.8%N/A0.1 $0.21 10/31/20241,200,000 shares $323.88 thousand +675.7%N/A0.2 $0.27 10/15/2024154,700 shares $22.42 thousand +164.9%N/A0 $0.14 9/30/202458,400 shares $10.50 thousand +349.2%N/A0 $0.18 9/15/202413,000 shares $4.61 thousand -78.8%N/A0 $0.35 8/31/202461,400 shares $22.10 thousand -80.2%N/A0 $0.36 8/15/2024310,700 shares $135.15 thousand -54.8%N/A0.1 $0.44 7/31/2024687,500 shares $277.27 thousand +2.9%N/A0.1 $0.40 7/15/2024668,300 shares $203.97 thousand +91.7%N/A0.1 $0.31 6/30/2024348,700 shares $106.70 thousand +1,552.6%N/A0.4 $0.31 6/15/202421,100 shares $16.20 thousand -55.8%0.5%0 $0.77 5/31/202447,700 shares $33.99 thousand -11.7%1.2%0.1 $0.71 5/15/202454,000 shares $43.63 thousand -79.9%1.3%0.1 $0.81 4/30/2024268,200 shares $190.61 thousand +84.2%16.8%0.3 $0.71 4/15/2024145,600 shares $114.00 thousand +324.5%9.1%0.6 $0.78 3/31/202434,300 shares $160.87 thousand +18.7%5.1%0.3 $4.69 3/15/202428,900 shares $156.64 thousand +725.7%5.5%0.3 $5.42 2/29/20243,500 shares $26.18 thousand -82.1%N/A0 $7.48 2/15/202419,600 shares $3.08 thousand +17.4%N/A0.1 $0.16 1/31/202416,700 shares $2.72 thousand -78.8%N/A0 $0.16 1/15/202478,900 shares $12.55 thousand -61.3%N/A0.2 $0.16 12/31/2023203,900 shares $36.91 thousand +253.4%N/A0.3 $0.18 12/15/202357,700 shares $9.92 thousand -46.0%N/A0.1 $0.17 11/30/2023106,800 shares $19.97 thousand +297.0%N/A0.2 $0.19 11/15/202326,900 shares $4.98 thousand -74.2%N/A0.1 $0.19 10/31/2023104,300 shares $29.49 thousand -19.3%N/A0.2 $0.28 10/15/2023129,200 shares $41.34 thousand +7.4%N/A0.3 $0.32"I'm risking my reputation on this" (Ad)How to transform tariff uncertainty into potential crypto profits. This book could be your guide to turning market uncertainty into financial freedom… Don't let this be the opportunity you regret missing for years to come.Claim your FREE copy of Crypto Revolution now. 9/30/2023120,300 shares $39.70 thousand +161.5%N/A0.4 $0.33 9/15/202346,000 shares $18.45 thousand -46.6%N/A0.1 $0.40 8/31/202386,200 shares $37.93 thousand +176.3%N/A0.3 $0.44 8/15/202331,200 shares $11.54 thousand -97.8%N/A0.1 $0.37 7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04 7/15/202335,300 shares $52.95 thousand +13.1%N/A0.2 $1.50 6/30/202331,200 shares $45.55 thousand +51.5%N/A0.6 $1.46 6/15/202320,600 shares $32.96 thousand -59.7%N/A0.4 $1.60 5/31/202351,100 shares $79.72 thousand -28.0%N/A1 $1.56 5/15/202371,000 shares $117.15 thousand -47.6%N/A1.3 $1.65 4/30/2023135,500 shares $260.16 thousand +47.8%N/A2.4 $1.92 4/15/202391,700 shares $174.23 thousand -35.1%N/A1.6 $1.90 3/31/2023141,200 shares $287.34 thousand +34.2%N/A2 $2.04 3/15/2023105,200 shares $190.41 thousand -30.1%N/A1.2 $1.81 2/28/2023150,400 shares $318.85 thousand +118.6%N/A0.2 $2.12 2/15/202368,800 shares $141.04 thousand -49.1%N/A0.1 $2.05 1/31/2023135,100 shares $310.73 thousand -27.3%N/A0.2 $2.30 1/15/2023185,800 shares $418.05 thousand -32.3%N/A0.2 $2.25 12/30/2022274,500 shares $636.84 thousand -38.8%N/A0.4 $2.32 12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25 11/30/202251,900 shares $161.93 thousand -2.8%N/A1.5 $3.12 11/15/202253,400 shares $178.89 thousand -12.3%N/A1.5 $3.35 10/31/202260,900 shares $183.92 thousand +6.8%N/A1.3 $3.02 10/15/202257,000 shares $161.31 thousand +8.6%N/A0.9 $2.83 9/30/202252,500 shares $159.60 thousand +23.8%N/A0.9 $3.04 9/15/202242,400 shares $158.58 thousand +3.9%N/A0.7 $3.74 8/31/202240,800 shares $144.43 thousand -4.5%N/A0.4 $3.54 8/15/202242,700 shares $195.99 thousand -48.9%N/A0.5 $4.59 7/31/202283,500 shares $328.99 thousand -9.3%N/A1 $3.94 7/15/202292,100 shares $361.03 thousand -30.2%N/A1.3 $3.92 6/30/2022132,000 shares $472.56 thousand -24.8%N/A1.4 $3.58 6/15/2022175,600 shares $579.48 thousand +20.9%N/A0.8 $3.30 5/31/2022145,200 shares $665.02 thousand +1.0%N/A0.7 $4.58 5/15/2022143,700 shares $661.02 thousand -13.4%N/A0.7 $4.60 4/30/2022165,900 shares $706.73 thousand -12.2%N/A0.7 $4.26 4/15/2022188,900 shares $899.16 thousand -6.3%N/A0.7 $4.76 3/31/2022201,600 shares $1.18 million +39.5%N/A0.8 $5.87 3/15/2022144,500 shares $647.36 thousand +1.4%N/A1 $4.48 2/28/2022142,500 shares $820.80 thousand -19.4%N/A0.6 $5.76 2/15/2022176,800 shares $1.11 million +247.4%N/A0.1 $6.29 1/31/202250,900 shares $297.26 thousand -65.8%N/A0 $5.84 1/15/2022148,600 shares $1.07 million -35.3%N/A0 $7.22 12/31/2021229,500 shares $1.81 million -25.8%N/A0.1 $7.87 12/15/2021309,400 shares $2.44 million -72.4%N/A0.1 $7.90 11/30/20211,120,000 shares $11.16 million +1,182.9%N/A0.3 $9.96 11/15/202187,300 shares $848.56 thousand +4.9%N/A0 $9.72 10/29/202183,200 shares $1.27 million +32.3%N/A1.6 $15.24 10/15/202162,900 shares $942.87 thousand +4.7%N/A1.4 $14.99 9/30/202160,100 shares $927.94 thousand -6.1%N/A1.2 $15.44 9/15/202164,000 shares $1.10 million -13.9%N/A1.2 $17.14New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 8/31/202174,300 shares $1.33 million -20.8%N/A1 $17.95 8/13/202193,800 shares $1.59 million -1.7%N/A1.2 $17.00 7/30/202195,400 shares $1.79 million -9.2%2.3%1.3 $18.77 7/15/2021105,100 shares $1.87 million -5.0%2.5%1.4 $17.75 6/30/2021110,600 shares $2.48 million +5.2%2.7%1.5 $22.43 6/15/2021105,100 shares $3.15 million -10.0%2.5%1.6 $30.00 5/28/2021116,800 shares $3.05 million +15.3%2.8%2.5 $26.12 5/14/2021101,300 shares $2.22 million -24.7%2.4%2.5 $21.93 4/30/2021134,600 shares $3.68 million +1.4%3.2%2.9 $27.34 4/15/2021132,800 shares $3.40 million -9.8%3.3%2.5 $25.57 3/31/2021147,300 shares $4.15 million -19.8%3.6%2.3 $28.20 3/15/2021183,600 shares $6.60 million -8.4%4.6%2.6 $35.97 2/26/2021200,500 shares $6.34 million +21.0%5.0%2.6 $31.62 2/12/2021165,700 shares $6.09 million +19.1%4.1%1.7 $36.76 1/29/2021139,100 shares $4.84 million +11.0%3.5%0.2 $34.83 1/15/2021125,300 shares $4.24 million -18.1%3.1%0.1 $33.82 12/31/2020153,000 shares $5.68 million -7.7%3.8%0.1 $37.11 12/15/2020165,800 shares $6.90 million -40.1%4.2%0.1 $41.61 11/30/2020276,700 shares $12.28 million -71.0%7.5%0.2 $44.39 11/15/2020955,400 shares $42.97 million +999.4%25.9%0.6 $44.98 10/30/202086,900 shares $572.67 thousand +2.4%3.0%0.1 $6.59 10/15/202084,900 shares $594.30 thousand -15.1%3.0%1.6 $7.00 9/30/2020100,000 shares $760 thousand +33.7%3.5%1.2 $7.60 9/15/202074,800 shares $596.16 thousand +9.2%2.6%0.1 $7.97 8/31/202068,500 shares $537.04 thousand -20.3%2.4%0.1 $7.84 8/14/202085,900 shares $684.62 thousand +39.7%3.0%0.1 $7.97 7/31/202061,500 shares $516.60 thousand +27.6%2.1%0.1 $8.40 7/15/202048,200 shares $352.34 thousand -75.1%1.7%0.1 $7.31 6/30/2020193,600 shares $1.62 million +147.6%6.7%0.3 $8.35 6/15/202078,200 shares $420.72 thousand -0.4%2.7%0.8 $5.38 APVO Short Interest - Frequently Asked Questions What is Aptevo Therapeutics' current short interest? Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 9,400 shares of APVO short. 1.39% of Aptevo Therapeutics' shares are currently sold short. Learn More on Aptevo Therapeutics' current short interest. What is a good short interest percentage for Aptevo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.39% of Aptevo Therapeutics' floating shares are currently sold short. Is Aptevo Therapeutics' short interest increasing or decreasing? Aptevo Therapeutics saw a decline in short interest during the month of May. As of May 31st, there was short interest totaling 9,400 shares, a decline of 55.0% from the previous total of 20,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aptevo Therapeutics' float size? Aptevo Therapeutics currently has issued a total of 405,000 shares. Some of Aptevo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptevo Therapeutics currently has a public float of 677,600 shares. How does Aptevo Therapeutics' short interest compare to its competitors? 1.39% of Aptevo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aptevo Therapeutics: Chromocell Therapeutics Co. (14.24%), Apollomics, Inc. (1.35%), Sunshine Biopharma, Inc. (3.80%), PharmaCyte Biotech, Inc. (0.27%), Mainz Biomed (1.09%), Omega Therapeutics, Inc. (26.99%), Pasithea Therapeutics Corp. (3.50%), AIM ImmunoTech Inc. (4.39%), Creative Medical Technology Holdings, Inc. (0.86%), Avalon GloboCare Corp. (2.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), Strategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Aptevo Therapeutics stock? Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. APVO shares are trading down $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptevo Therapeutics? A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further. How often is Aptevo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies CHRO Short Interest Data APLM Short Interest Data SBFM Short Interest Data PMCB Short Interest Data MYNZ Short Interest Data OMGA Short Interest Data KTTA Short Interest Data AIM Short Interest Data CELZ Short Interest Data ALBT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APVO) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
